Joe Biden
Commences New Phase in Cancer Therapy
Published October 11, 2025 8:58 AM PDT
The former President Joe Biden is entering a vital new stage in his battle against an aggressive form of prostate cancer.
A Biden spokesperson confirmed to NBC News, stating, āAs part of his treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy alongside hormone treatments.ā
According to NBC, the radiation therapy is set to last approximately five weeks, and the soon-to-be 83-year-old Biden has already been on a pill-form hormone medication.
In May, Biden disclosed his diagnosis of an āaggressive formā of prostate cancer that had metastasized to his bones, mentioning that he and his family were “considering treatment options with his doctors.”
It seems a strategic plan has been chosen. Wishing you a swift recovery, Joe.
Related articles
wbq.push(function gdprConnatix() {
var response = ‘unknown’;
function accept() {
if (response === ‘accepted’) {
return;
}
(function () {
if (typeof window.cnxps !== ‘undefined’) {
return;
}
window.cnxps = {};
window.cnxps.cmd = [];
!function (n) {
var t = n.createElement(‘iframe’);
t.src = “https://www.tmz.com/2025/10/11/joe-biden-starting-radiation-prostate-cancer/javascript:false”;
t.display = ‘none’;
t.onload = function () {
var n = t.contentWindow.document;
var c = n.createElement(‘script’);
c.src = ‘//cd.connatix.com/connatix.playspace.js’;
c.setAttribute(‘async’, ‘1’);
c.setAttribute(‘type’, ‘text/javascript’);
n.body.appendChild(c);
};
n.head.appendChild(t);
}(document);
})();
(function () {
if (typeof window.cnx !== ‘undefined’) {
return;
}
window.cnx = {};
window.cnx.cmd = [];
!function (n) {
var t = n.createElement(‘iframe’);
t.src = “https://www.tmz.com/2025/10/11/joe-biden-starting-radiation-prostate-cancer/javascript:false”;
t.display = ‘none’;
t.onload = function () {
var n = t.contentWindow.document;
var c = n.createElement(‘script’);
c.src = ‘//cd.connatix.com/connatix.player.js?cid=4365136b-b376-11e9-b4d2-06948452ae1a’;
c.setAttribute(‘async’, ‘1’);
c.setAttribute(‘type’, ‘text/javascript’);
n.body.appendChild(c);
};
n.head.appendChild(t);
}(document);
})();
response = ‘accepted’;
}
function reject() {
if (response === ‘rejected’) {
return;
}
response = ‘rejected’;
}
watchConsent(function(canUse) {
canUse(‘connatix’) ? accept() : reject();
});
});
window.wbq = window.wbq || [];
window.wbq.push(function loadOutbrainSmartfeed(app = window.TMZ) {
const outbrainDiv = document.getElementById(‘outbrain-permalink’);
const page = app.select(app.selectors.getPage);
if (!page?.url) {
outbrainDiv.parentNode.removeChild(outbrainDiv);
return;
}
if (window.DEVICE_VIEW === ‘smartphone’) {
outbrainDiv.style.backgroundColor = ‘white’;
outbrainDiv.style.display = ‘flex’;
}
const smartfeedDiv = document.createElement(‘div’);
smartfeedDiv.setAttribute(‘data-widget-id’, ‘AR_1’);
smartfeedDiv.setAttribute(‘data-src’, page.url);
smartfeedDiv.className = ‘OUTBRAIN’;
const script = document.createElement(‘script’);
script.type = ‘text/javascript’;
script.setAttribute(‘async’, ‘async’);
script.src = ‘https://widgets.outbrain.com/outbrain.js’;
outbrainDiv.appendChild(smartfeedDiv);
outbrainDiv.appendChild(script);
});
